文献速递糖尿病肥胖与代谢综合征垂体与肾上腺疾病

改善血脂异常青少年的长期结局——拓展儿科内分泌医生的角色

Improving Long-Term Outcomes of Youth With Lipid Abnormalities-Expanding the Role of Pediatric Endocrinologists.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

本文综述儿童血脂异常高发现状,指出除单基因脂代谢病外,糖尿病、生长激素缺乏、先天性肾上腺增生及垂体功能减退等常见内分泌病也增加心血管病风险。作者建议对这类青少年进行胆固醇筛查,部分需早期降脂干预,并呼吁扩充临床服务和加强儿科内分泌医生教育。

要点

  • 儿童血脂异常患病率高,常见内分泌病也增加心血管病风险。
  • 1型和2型糖尿病等青少年应接受胆固醇筛查,部分需早期降脂。
  • 血脂异常诊疗服务及有经验医生可能不足,需扩充并加强教育。

核心结论

  • 儿童血脂异常患病率高,常见内分泌病增加早发心血管病风险。
  • 亟需扩充临床服务并对儿科内分泌医生开展针对性教育。

研究设计与样本

  • 综述现有文献并汇总儿科内分泌意见领袖讨论,非系统检索。

主要发现

  • 单基因脂代谢病心血管风险已被认识,常见内分泌病相关风险相对少被识别。
  • 1型和2型糖尿病等常见内分泌病青少年可从胆固醇筛查和早期干预中获益。
  • 血脂异常青少年可及的服务地点、范围及有经验医生情况 largely unknown 但可能不足。

关键数值与推荐

  • 常见内分泌病青少年应接受胆固醇筛查,部分需早期降脂药物治疗。

临床怎么用

  • 儿科内分泌医生应关注糖尿病、生长激素缺乏、先天性肾上腺增生及垂体功能减退患者的血脂筛查。

局限性

  • 本文为文献综述与专家讨论汇总,未报告系统检索策略或原始研究数据。
  • 血脂异常服务可及性和有经验医生情况 largely unknown。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: There is a disturbingly high prevalence of dyslipidemia in youth. Although pediatric endocrinologists are aware of the substantial cardiovascular (CV) risk associated with monogenic disorders of lipid and lipoprotein metabolism, relatively few recognize the CV disease (CVD)-related morbidity and premature mortality incurred by common endocrine disorders associated with dyslipidemia, such as diabetes mellitus, growth hormone deficiency, congenital adrenal hyperplasia, and hypopituitarism. OBJECTIVE: In this article, we discuss the expanding role of pediatric endocrinologists in CV health and risk prevention. DESIGN: We reviewed available literature and summarized discussions with opinion leaders in pediatric endocrinology to accomplish the following: (i) provide an overview of this timely topic; (ii) identify opportunities for targeted education; and (iii) discuss ways of expanding clinical services to improve outcomes. RESULTS: In addition to well-known genetic disorders of lipid and lipoprotein metabolism, youth with common endocrine disorders, including type 1 and type 2 diabetes, would benefit from cholesterol screening and in some, early intervention, including use of lipid-lowering medications. Despite the growing need, the location and extent of services available to youth with dyslipidemia and the availability of providers with experience in treatment of dyslipidemia are largely unknown but likely inadequate to provide accessible, timely, and cost-effective intervention. CONCLUSION: With a new awareness of opportunities to prevent premature CVD in youth, including those with common endocrine disorders and CVD-related events during adulthood, there is an urgent need for additional clinical services and targeted education of current as well as future pediatric endocrinologists.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ashraf AP, Kohn B, Wilson DP, et al. Improving Long-Term Outcomes of Youth With Lipid Abnormalities-Expanding the Role of Pediatric Endocrinologists. J Clin Endocrinol Metab. 2019. PMID: 31120509. doi:10.1210/jc.2019-00150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。